Epidemiologie und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) unter Genderaspekten

Standard

Epidemiologie und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) unter Genderaspekten. / Stoberock, K.; Debus, E. S.; Atlihan, G.; Eifert, S.; Larena-Avellaneda, A.; Wipper, S.

In: GEFASSCHIRURGIE, Vol. 19, No. 2, 03.2014, p. 109-116.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{17d3205c9aa9467283c324b1b16d5fe6,
title = "Epidemiologie und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) unter Genderaspekten",
abstract = "Objective: This literature review comments on gender differences for prevalence, epidemiology, risk factors and therapy in patients with peripheral arterial occlusive disease (PAOD). Material and methods: For the literature review Medline (PubMed) was searched for relevant studies on PAOD before December 2013. Keywords used were {"}peripheral arterial disease{"}, {"}gender{"}, {"}bypass{"}, {"}intervention{"} and {"}outcome{"}. Results: Women have a higher age-adjusted risk for PAOD and for women it is more often asymptomatic so that the disease is treated at an advanced stage. According to some studies women receive secondary prophylactic measures and interventional or surgical treatment less often than men. In addition, they suffer more frequently from bypass failure, impaired wound healing, bleeding complications and amputation. On the other hand, studies after infrainguinal reconstruction show similar patency and limb salvage rates to men and the differences for subsequent endovascular therapy are also only marginal. Possible reasons for the differences may be, besides the gender-specific cardiovascular risk profile, the estrogen concentration and different anatomical conditions with different vessel calibres. Conclusion: In PAOD there are gender differences. Clear guidelines for gender-specific treatment recommendations do not exist; however, they would be important for the long-term therapeutic success.",
keywords = "Bypass, Gender, Intervention, Outcome, Peripheral arterial disease",
author = "K. Stoberock and Debus, {E. S.} and G. Atlihan and S. Eifert and A. Larena-Avellaneda and S. Wipper",
year = "2014",
month = mar,
doi = "10.1007/s00772-013-1270-1",
language = "Deutsch",
volume = "19",
pages = "109--116",
journal = "GEFASSCHIRURGIE",
issn = "0948-7034",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Epidemiologie und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) unter Genderaspekten

AU - Stoberock, K.

AU - Debus, E. S.

AU - Atlihan, G.

AU - Eifert, S.

AU - Larena-Avellaneda, A.

AU - Wipper, S.

PY - 2014/3

Y1 - 2014/3

N2 - Objective: This literature review comments on gender differences for prevalence, epidemiology, risk factors and therapy in patients with peripheral arterial occlusive disease (PAOD). Material and methods: For the literature review Medline (PubMed) was searched for relevant studies on PAOD before December 2013. Keywords used were "peripheral arterial disease", "gender", "bypass", "intervention" and "outcome". Results: Women have a higher age-adjusted risk for PAOD and for women it is more often asymptomatic so that the disease is treated at an advanced stage. According to some studies women receive secondary prophylactic measures and interventional or surgical treatment less often than men. In addition, they suffer more frequently from bypass failure, impaired wound healing, bleeding complications and amputation. On the other hand, studies after infrainguinal reconstruction show similar patency and limb salvage rates to men and the differences for subsequent endovascular therapy are also only marginal. Possible reasons for the differences may be, besides the gender-specific cardiovascular risk profile, the estrogen concentration and different anatomical conditions with different vessel calibres. Conclusion: In PAOD there are gender differences. Clear guidelines for gender-specific treatment recommendations do not exist; however, they would be important for the long-term therapeutic success.

AB - Objective: This literature review comments on gender differences for prevalence, epidemiology, risk factors and therapy in patients with peripheral arterial occlusive disease (PAOD). Material and methods: For the literature review Medline (PubMed) was searched for relevant studies on PAOD before December 2013. Keywords used were "peripheral arterial disease", "gender", "bypass", "intervention" and "outcome". Results: Women have a higher age-adjusted risk for PAOD and for women it is more often asymptomatic so that the disease is treated at an advanced stage. According to some studies women receive secondary prophylactic measures and interventional or surgical treatment less often than men. In addition, they suffer more frequently from bypass failure, impaired wound healing, bleeding complications and amputation. On the other hand, studies after infrainguinal reconstruction show similar patency and limb salvage rates to men and the differences for subsequent endovascular therapy are also only marginal. Possible reasons for the differences may be, besides the gender-specific cardiovascular risk profile, the estrogen concentration and different anatomical conditions with different vessel calibres. Conclusion: In PAOD there are gender differences. Clear guidelines for gender-specific treatment recommendations do not exist; however, they would be important for the long-term therapeutic success.

KW - Bypass

KW - Gender

KW - Intervention

KW - Outcome

KW - Peripheral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=84909985875&partnerID=8YFLogxK

U2 - 10.1007/s00772-013-1270-1

DO - 10.1007/s00772-013-1270-1

M3 - SCORING: Review

AN - SCOPUS:84909985875

VL - 19

SP - 109

EP - 116

JO - GEFASSCHIRURGIE

JF - GEFASSCHIRURGIE

SN - 0948-7034

IS - 2

ER -